335 Towards an implantable replenishable delivery device for natural killer cell and Tri-specific killer engager antibodies to the intraperitoneal space to treat ovarian cancer

BackgroundOvarian cancer (OC) global 5-year survival rate is

Saved in:
Bibliographic Details
Published in:Journal for immunotherapy of cancer 2023-11, Vol.11 (Suppl 1), p.A384-A384
Main Authors: Sheedy, Aoibhin, Selleck, Carly, Ward, Niamh, Trask, Lesley, Duffy, Garry, Geller, Melissa A, Miller, Jeffrey S, Dolan, Eimear, Felices, Martin
Format: Article
Language:English
Subjects:
Catheters
Chemotherapy
Cytotoxicity
Immunotherapy
Ovarian cancer
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BackgroundOvarian cancer (OC) global 5-year survival rate is
ISSN:2051-1426
DOI:10.1136/jitc-2023-SITC2023.0335